Medical Xpress September 9, 2024
In a new study published in Circulation: Cardiovascular Quality and Outcomes, researchers at Yale School of Medicine say an artificial intelligence (AI) tool can use electrocardiographic (ECG) images to define the risk of cardiac dysfunction for patients undergoing cancer treatments.
“There are certain treatments for breast cancer and lymphomas, such as anthracyclines and trastuzumab, that have cardiotoxic effects,” said Rohan Khera, MD, Assistant Professor of Medicine, Director of the Cardiovascular Data Science (CarDS) Lab, and senior author of the study. “1 in 10 individuals receiving these drugs individually, and nearly 1 in 3 using the drugs in combination, have adverse cardiac reactions.”
After identifying 1,550 patients who had received anthracyclines or trastuzumab to treat breast cancer or non-Hodgkin lymphoma, researchers...
Today's Sponsors
Today's Sponsor